McKesson Reaches Agreement in Principle to Extend CVS Health Partnership
McKesson (MCK) shares rose 4.4% after reaching an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
McKesson Extends CVS Health Pact To 2032
McKesson Corp. (MCK) has signed an agreement in principle to extend its partnership with CVS Health Corp. (CVS) to supply medicines through 2032. The company also reaffirmed its FY27 Adjusted EPS guidance.
McKesson Corporation (MCK) Extends CVS Distribution Agreement to 2032
McKesson signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032 and reaffirmed FY2027 adjusted EPS guidance of $44.20—$45.00 and a long-term adjusted EPS growth rate of 13%—16%.Material DetailsContext by AI AnalystThis is a late conf…
McKesson Extends CVS Health Pharmaceutical Distribution Agreement to 2032
McKesson Corporation has signed an agreement in principle to extend its pharmaceutical distribution partnership with CVS Health through June 2032. The agreement covers distribution to mail order and specialty pharmacies, retail pharmacies, and distribution centers.